Consolidated Statement of Operations Data (1)(2)(3)(4)(5)(6):
Revenues
$
1,647,824
$
1,427,933
$
1,656,750
$
1,429,061
$
1,566,162
Income from continuing operations
81,272
164,947
217,049
343,957
379,692
Net income
$
81,272
$
164,947
$
217,049
$
369,873
$
384,820
Income from continuing operations per common share—basic
$
0.40
$
0.86
$
1.16
$
1.86
$
2.11
Income from continuing operations per common share—diluted
$
0.37
$
0.70
$
0.94
$
1.52
$
1.73
Net income per common share—basic
$
0.40
$
0.86
$
1.16
$
2.00
$
2.14
Net income per common share—diluted
$
0.37
$
0.70
$
0.94
$
1.63
$
1.75
Cash dividend declared per common share
$
0.18
$
—
$
—
$
—
$
—
Consolidated Balance Sheet Data:
Total assets
$
2,538,520
$
2,629,824
$
2,429,345
$
2,188,639
$
1,810,355
Short-term debt obligations
—
186,663
2,328
2,573
2,450
Long-term debt obligations
$
—
$
—
$
171,059
$
159,956
$
150,182
(1)
The Consolidated Statement of Operations Data for the year ended December 31, 2014 includes a $98.9 million goodwill impairment charge related to the Wireless Test segment and $46.6 million of pension actuarial losses.
(2)
The Consolidated Statement of Operations Data for the year ended December 31, 2013 includes a $34.2 million gain from the sale of an equity investment and $10.3 million of pension actuarial gains.
(3)
The Consolidated Statement of Operations Data for the year ended December 31, 2012 includes $23.3 million of pension actuarial losses.
(4)
As a result of the divestiture of Diagnostic Test Solutions in 2011, we are reporting this business unit as discontinued operations for 2011 and 2010.
(5)
The Consolidated Statement of Operations Data for the year ended December 31, 2011 includes the results of operations of LitePoint from October 5, 2011.
(6)
The Consolidated Statement of Operations Data for the year ended December 31, 2011 includes a tax benefit of $129.5 million due primarily to the release of the deferred tax valuation allowance and $13.6 million of pension actuarial losses.
filings.tools